U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT07480330) titled 'Serum Neurofilament Light Chain Levels and Neuropathy Severity in Diabetic Polyneuropathy' on March 14.
Brief Summary: Diabetic polyneuropathy (DPN) is one of the most common chronic complications of diabetes mellitus and is characterized by peripheral nerve damage caused by long-term hyperglycemia. Progressive sensory loss and impairment of proprioception may lead to balance disturbances, gait instability, and an increased risk of falls. Neurofilament Light Chain (NfL) has emerged as a potential biomarker of neuroaxonal injury in several neurological disorders.
The aim of this observational cross-sectional study is to investigate...